Investigation of MicroRNA Biomarkers in Equine Distal Interphalangeal Joint Osteoarthritis

Int J Mol Sci. 2022 Dec 8;23(24):15526. doi: 10.3390/ijms232415526.

Abstract

Osteoarthritis of the equine distal interphalangeal joint is a common cause of lameness. MicroRNAs from biofluids are promising biomarkers and therapeutic candidates. Synovial fluid samples from horses with mild and severe equine distal interphalangeal joint osteoarthritis were submitted for small RNA sequencing. The results demonstrated that miR-92a was downregulated in equine synovial fluid from horses with severe osteoarthritis and there was a significant increase in COMP, COL1A2, RUNX2 and SOX9 following miR-92a mimic treatment of equine chondrocytes in monolayer culture. This is the first equine study to evaluate the role of miR-92a in osteoarthritic chondrocytes in vitro.

Keywords: biomarkers; distal interphalangeal joint; equine; microRNA; osteoarthritis; synovial fluid.

MeSH terms

  • Animals
  • Biomarkers
  • Horses
  • Joints
  • Osteoarthritis* / genetics
  • Osteoarthritis* / therapy
  • Osteoarthritis* / veterinary
  • Synovial Fluid

Substances

  • Collagen Type I, alpha2 Subunit
  • Biomarkers